" Knowing that I no longer have residual
disease would mean peace of mind."
Black Swan Research Initiative Updates
Next-Generation Flow article published in the journal Leukemia
The article “Next Generation Flow for highly sensitive and standardized detection of minimal
CNN Interview Highlighting IMF-Funded Myeloma Research Project in Iceland
In the latest episode of “Vital Signs,” CNN Chief Medical Correspondent Dr. Sanjay Gupta
What is the latest in the Black Swan Research Initiative?
Made up of an exciting team of multinational researchers, the Black Swan Research Initiative®
A Major Step Forward for the IMF’s Black Swan Research Initiative®
The IMF’s Black Swan Research Initiative® took a major step forward this week in its mission to
What is iStopMM
As the IMF’s President and Co-Founder Susie Novis Durie states in this compelling video,
Next-Generation Flow article published in the journal Leukemia
The article “Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma” was published in the latest issue of the journal Leukemia. This
CNN Interview Highlighting IMF-Funded Myeloma Research Project in Iceland
In the latest episode of “Vital Signs,” CNN Chief Medical Correspondent Dr. Sanjay Gupta travels to Iceland, where he interviews International Myeloma Foundation Chairman Dr. Brian Durie and
What is the latest in the Black Swan Research Initiative?
Made up of an exciting team of multinational researchers, the Black Swan Research Initiative® team has developed a way to monitor the status of myeloma at very low levels, or minimal residual
A Major Step Forward for the IMF’s Black Swan Research Initiative®
The IMF’s Black Swan Research Initiative® took a major step forward this week in its mission to achieve a cure for myeloma. A study published in the journal Leukemia definitively establishes Next
What is iStopMM
As the IMF’s President and Co-Founder Susie Novis Durie states in this compelling video, “iStopMM and the Black Swan Research Initiative are just hand and glove; it (iStopMM) is just part of
iStop MM® gets off to a fast start
The IMF team just returned from the exciting iStopMM kickoff meeting held September 26-27th at the deCode Genetics facility at the University of Iceland in Reykjavik. A major project funded by the
Precision Oncology and the Cancer Moonshot: Where Do We Stand?
There have been recent commentaries on the prospects and potential for both what is called "precision oncology" and Vice President Joe Biden's Cancer Moonshot program. Although I have discussed both
Four Important Ways Iceland’s iStopMM Research Project Will Help Myeloma Patients Globally
The iStopMM research project is about to get started in Iceland. It is supported through the IMF’s Black Swan Research Initiative® and literally will
Preview of the Black Swan Research Initiative’s First US Cure Trial
Dr. Shaji Kumar shares the details of the upcoming US ASCENT “Cure Trial” in a video interview on IMF-TV. ASCENT stands for Aggressive Smoldering Cure Evaluating Novel Rx Transplant. This
Understanding the Nature of MRD-Positive Myeloma
A study in the journal Blood reports for the first time the biological features of MRD (minimal residual disease) cells in myeloma and shows that clonal selection is already present at the MRD stage.
